Functional Effects of EPS-Producing Bifidobacterium Administration on Energy Metabolic Alterations of Diet-Induced Obese Mice
- PMID: 31440225
- PMCID: PMC6693475
- DOI: 10.3389/fmicb.2019.01809
Functional Effects of EPS-Producing Bifidobacterium Administration on Energy Metabolic Alterations of Diet-Induced Obese Mice
Abstract
Obesity has been recognized by the World Health Organization as a global epidemic. The gut microbiota is considered as a factor involved in the regulation of numerous metabolic pathways by impacting several functions of the host. It has been suggested that probiotics can modulate host gene expression and metabolism, and thereby positively influence host adipose tissue development and obesity related-metabolic disorders. The aim of the present work was to evaluate the effect of an exopolysaccharide (EPS)-producing Bifidobacterium strain on host glucose and lipid metabolism and the gut microbial composition in a short-term diet-induced obesity (DIO) in mice. C57BL/6J male mice were randomly divided into three groups: a control group that received control standard diet, a group fed a high-fat diet (HF), and a group fed HF supplemented with Bifidobacterium animalis IPLA R1. Fasting serum insulin as well as triglycerides accumulation in the liver were significantly reduced in the group receiving B. animalis IPLA R1. The treatment with the EPS-producing B. animalis IPLA R1 tended to down-regulate the expression of host genes involved in the hepatic synthesis of fatty acids which was concomitant with an upregulation in the expression of genes related with fatty acid oxidation. B. animalis IPLA R1 not only promoted the increase of Bifidobacterium but also the levels of Bacteroides-Prevotella. Our data indicate that the EPS-producing Bifidobacterium IPLA R1 strain may have beneficial effects in metabolic disorders associated with obesity, by modulating the gut microbiota composition and promoting changes in lipids metabolism and glucose homeostasis.
Keywords: Bifidobacterium; bile acids; fatty acid oxidation; gut microbiota; liver fatty acid profile; obesity.
Figures




Similar articles
-
Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats.Int J Food Microbiol. 2011 Jan 5;144(3):342-51. doi: 10.1016/j.ijfoodmicro.2010.10.016. Int J Food Microbiol. 2011. PMID: 21078530
-
Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.Int J Food Microbiol. 2009 Nov 15;135(3):260-7. doi: 10.1016/j.ijfoodmicro.2009.08.017. Epub 2009 Aug 19. Int J Food Microbiol. 2009. PMID: 19735956
-
Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice.PLoS One. 2011;6(6):e20944. doi: 10.1371/journal.pone.0020944. Epub 2011 Jun 9. PLoS One. 2011. PMID: 21695273 Free PMC article.
-
Bifidobacterium animalis subsp. lactis lkm512 Attenuates Obesity-Associated Inflammation and Insulin Resistance Through the Modification of Gut Microbiota in High-Fat Diet-Induced Obese Mice.Mol Nutr Food Res. 2022 Feb;66(3):e2100639. doi: 10.1002/mnfr.202100639. Epub 2021 Dec 10. Mol Nutr Food Res. 2022. PMID: 34847296
-
Bifidobacterium animalis subspecies lactis engineered to produce mycosporin-like amino acids in colorectal cancer prevention.SAGE Open Med. 2019 Jan 22;7:2050312119825784. doi: 10.1177/2050312119825784. eCollection 2019. SAGE Open Med. 2019. PMID: 30719295 Free PMC article. Review.
Cited by
-
Anti-Inflammatory Effects of Limosilactobacillus fermentum KGC1601 Isolated from Panax ginseng and Its Probiotic Characteristics.Foods. 2022 Jun 10;11(12):1707. doi: 10.3390/foods11121707. Foods. 2022. PMID: 35741904 Free PMC article.
-
Effects of lactic acid bacteria isolated from dairy products on lipid pattern of rats fed with a high fat diet.Iran J Microbiol. 2025 Jun;17(3):434-440. doi: 10.18502/ijm.v17i3.18826. Iran J Microbiol. 2025. PMID: 40612728 Free PMC article.
-
Lactobacillus murinus Improved the Bioavailability of Orally Administered Glycyrrhizic Acid in Rats.Front Microbiol. 2020 Apr 24;11:597. doi: 10.3389/fmicb.2020.00597. eCollection 2020. Front Microbiol. 2020. PMID: 32390962 Free PMC article.
-
Role of Postbiotics in Diet-Induced Metabolic Disorders.Nutrients. 2022 Sep 7;14(18):3701. doi: 10.3390/nu14183701. Nutrients. 2022. PMID: 36145077 Free PMC article. Review.
-
Exopolysaccharide production in fermented milk using Lactobacillus casei strains AP and AG.AIMS Microbiol. 2022 Apr 25;8(2):138-152. doi: 10.3934/microbiol.2022012. eCollection 2022. AIMS Microbiol. 2022. PMID: 35974991 Free PMC article.
References
-
- Bigliardi B., Galati F. (2013). Innovation trends in the food industry: the case of functional foods. Trends Food Sci. Technol. 31 118–129. 10.1016/j.tifs.2013.03.006 - DOI
-
- Bindels L. B., Neyrinck A. M., Salazar N., Taminiau B., Druart C., Muccioli G. G., et al. (2015). Non digestible oligosaccharides modulate the gut microbiota to control the development of leukemia and associated cachexia in mice. PLoS One 10:e0131009. 10.1371/journal.pone.0131009 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous